Teva lands a new Chief Executive

By Catherine Sturman
Israeli based pharmaceutical company Teva has been searching for a new Chief Executive since February. However, it seems the search is finally over. It...

Israeli based pharmaceutical company Teva has been searching for a new Chief Executive since February. However, it seems the search is finally over.

It has recently been announced that Kare Schultz has been appointed as Teva Pharmaceuticals new Chief Executive, becoming the second non-Israeli to provide significant leadership in order to ensure Teva remains competitive and can overcome current challenges.

He takes over from previous Chief Executive Erez Vigodman and Yitzhak Peterburg.

The healthcare sector is currently undergoing a significant transformation, with increased digitisation, falling drug prices and need to further the brand’s expansion. Since the death of previous Chief Executive, Eli Hurvitz in 2011, the company has fought to overcome its struggles, but many individuals have not adopted the tenacity needed within the role.

Related stories

Teva’s shares have been under significant pressure amongst new competitors which have hit the market. Schultz’s appointment with restore the company’s credibility, especially with potential investors and has seen share prices rise as the news broke.

Schultz’s move to Israel will showcase his commitment to the company, where he will create a new strategy in which to move the company forward, as well as look at Teva’s $35 billion debt which it acquired through the purchase of Allergan’s generic business.

To counteract this financial instability, the company has recently sold its women’s health unit , alongside its contraceptive brand Paraguard to Cooper Cos for $1.1 billion.

With 30 years in the pharmaceutical business, Schultz has worked at Novo Nordisk A/S and H. Lundbeck A/S, overseeing the company’s operations and leading Lundbeck A/S to success through restructuring the business in order for it to remain financially stable.

 

Share

Featured Articles

Johnson & Johnson: Turning supplier spend into local support

Johnson & Johnson’s Global Supplier Diversity & Inclusion team is growing spending with social enterprises around the globe to expand its impact

Seasonal Affective Disorder’s impact on health & solutions

Dr Ravi Gill & Dr. Naomi Newman-Beinart discuss Seasonal Affective Disorder and its treatments, from vitamin D spray to light therapy

CGI teams up with Totalmobile for digital healthcare service

CGI is driving efficiency in healthcare. Hear from Helena Jochberger, at Manufacturing Digital LIVE, a free virtual event on Wednesday 6th December 2023

Deloitte: generative AI can improve access to healthcare

Technology & AI

Wipro & NVIDIA’s revolutionary healthcare uses generative AI

AI & ML

Healthtech platform CoverSelf extends seed round to US$8.2m

Technology & AI